MetLife Investment Management’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-8,997
| Closed | -$149K | – | 2832 |
|
|
2024
Q3 | $149K | Buy |
+8,997
| New | +$149K | ﹤0.01% | 2439 |
|
|
2024
Q2 | – | Sell |
-7,248
| Closed | -$69.9K | – | 2904 |
|
|
2024
Q1 | $69.9K | Buy |
+7,248
| New | +$69.9K | ﹤0.01% | 2666 |
|
|
2023
Q2 | – | Sell |
-5,702
| Closed | -$78.3K | – | 2963 |
|
|
2023
Q1 | $78.3K | Hold |
5,702
| – | – | ﹤0.01% | 2648 |
|
|
2022
Q4 | $97K | Hold |
5,702
| – | – | ﹤0.01% | 2605 |
|
|
2022
Q3 | $130K | Buy |
5,702
+306
| +6% | +$6.96K | ﹤0.01% | 2550 |
|
|
2022
Q2 | $97.3K | Buy |
+5,396
| New | +$97.3K | ﹤0.01% | 2721 |
|
|
2022
Q1 | – | Sell |
-3,333
| Closed | -$97.8K | – | 2747 |
|
|
2021
Q4 | $97.8K | Hold |
3,333
| – | – | ﹤0.01% | 2412 |
|
|
2021
Q3 | $219K | Hold |
3,333
| – | – | ﹤0.01% | 2030 |
|
|
2021
Q2 | $277K | Hold |
3,333
| – | – | ﹤0.01% | 1939 |
|
|
2021
Q1 | $256K | Hold |
3,333
| – | – | ﹤0.01% | 1915 |
|
|
2020
Q4 | $294K | Hold |
3,333
| – | – | ﹤0.01% | 1781 |
|
|
2020
Q3 | $246K | Hold |
3,333
| – | – | ﹤0.01% | 1732 |
|
|
2020
Q2 | $243K | Buy |
3,333
+896
| +37% | +$65.4K | ﹤0.01% | 1785 |
|
|
2020
Q1 | $137K | Buy |
+2,437
| New | +$137K | ﹤0.01% | 1900 |
|